Delirium, Intraoperative Cerebral Perfusion and EEG Abnormalities After Total Hip Arthroplasty

NCT ID: NCT02818764

Last Updated: 2020-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

3 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-30

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of this study is to test for perturbations in intraoperative electroencephalogram (EEG) , cerebral blood flow (CBF), cerebral metabolic rate of oxygen consumption (CMRO2), oxygen extraction fraction (OEF), and serum and cerebral spinal fluid biomarkers associated with delirium in high risk population having elective hip arthroplasty at Penn Presbyterian Medical Center (PPMC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All prospective patients will be given a copy of the informed consent which explains the details and responsibilities of the study.

Each patient will have a preoperative baseline 3D-CAM and MOCA to document preoperative cognitive function and possible criteria for exclusion.

1. The 3D -Confusion Assessment Method (CAM) test is a clinician evaluation and algorithm for the binary determination of presence or absence of delirium.
2. Montreal Confusion Assessment (MOCA) - to be given preoperatively to determine if element of pre-existing cognitive impairment

Intraoperatively each patient will have a NIR Optode patch placed to measure intraoperative cerebral blood flow and oxygen extraction fraction and cerebral metabolic rate of oxygen consumption.

A non-invasive frontal EEG patch will be placed prior to or at the start of anesthesia. Anesthetic depth will be measured using the SEDline® by Masimo. Continuous raw EEG, spectral edge, compressed spectral analysis and percentage suppressed will be recorded from the SEDline® monitor.

The investigators will be drawing blood from patients who agree to participate in the study. Preoperative blood sampling will be done while the investigators place the intravenous line, or if present, from an arterial line.

If a spinal anesthetic is being used, 5 mL of cerebral spinal fluid (CSF) will be collected at the time of dural puncture prior to the administration of the neuraxial blockade.

Members of the research team will administer 3D-CAM testing on post-operative days 1 and 2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Delirium Hip Arthroplasty Elderly

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

serum biomarkers cerebral blood flow modified Blessed Dementia Rating scale Confusion Assessment Method Delirium Rating Scale-98

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Delirium

Subjects undergoing elective total joint arthroplasty determined to have delirium by post operative 3D-CAM.

Data collected on intraoperative cerebral blood flow and oxygen extraction fraction.

CSF collected for biomarkers. Blood colelcted for biomarkers.

Blood Draw

Intervention Type PROCEDURE

5 mL of blood from the patients preoperative, postoperative, 1 day and 2 days after surgery for a total of 20 mL.

Cerebral Spinal Fluid collection

Intervention Type PROCEDURE

Fluid collected at the time of dural puncture if patients will undergo spinal anesthesia

Electroencephalogram

Intervention Type DEVICE

Test used to detect abnormalities related to electrical activity of the brain will be done during surgery.

Cerebral blood flow and oxygen extraction fraction

Intervention Type DEVICE

NIRS measurement of Cerebral blood flow and cerebral tissue oxygen concentration.

Non-delirium

Subjects undergoing elective total joint arthroplasty determined not to have delirium by post oeprative 3D-CAM.

Data collected on intraoperative cerebral blood flow and oxygen extraction fraction.

CSF collected for biomarkers. Blood colelcted for biomarkers.

Blood Draw

Intervention Type PROCEDURE

5 mL of blood from the patients preoperative, postoperative, 1 day and 2 days after surgery for a total of 20 mL.

Cerebral Spinal Fluid collection

Intervention Type PROCEDURE

Fluid collected at the time of dural puncture if patients will undergo spinal anesthesia

Electroencephalogram

Intervention Type DEVICE

Test used to detect abnormalities related to electrical activity of the brain will be done during surgery.

Cerebral blood flow and oxygen extraction fraction

Intervention Type DEVICE

NIRS measurement of Cerebral blood flow and cerebral tissue oxygen concentration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Draw

5 mL of blood from the patients preoperative, postoperative, 1 day and 2 days after surgery for a total of 20 mL.

Intervention Type PROCEDURE

Cerebral Spinal Fluid collection

Fluid collected at the time of dural puncture if patients will undergo spinal anesthesia

Intervention Type PROCEDURE

Electroencephalogram

Test used to detect abnormalities related to electrical activity of the brain will be done during surgery.

Intervention Type DEVICE

Cerebral blood flow and oxygen extraction fraction

NIRS measurement of Cerebral blood flow and cerebral tissue oxygen concentration.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CSF EEG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients 65 years of age and over scheduled for elective total joint arthroplasty
2. Mentally competent and able to give consent for enrollment in the study
3. Patients at any age with a pre-existing diagnosis of dementia or acquired cognitive deficit. Consented by legally authorized representative (LAR).

Exclusion Criteria

1. Patients currently delirious
2. Acute neurological disease like stroke or brain tumor
3. Current alcohol or substance abuse at risk of postoperative withdrawal
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew W Kofke, MD MBA FCCM

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. doi: 10.1176/jnp.13.2.229.

Reference Type BACKGROUND
PMID: 11449030 (View on PubMed)

Fong TG, Bogardus ST Jr, Daftary A, Auerbach E, Blumenfeld H, Modur S, Leo-Summers L, Seibyl J, Inouye SK. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1294-9. doi: 10.1093/gerona/61.12.1294.

Reference Type BACKGROUND
PMID: 17234823 (View on PubMed)

Gokgoz L, Gunaydin S, Sinci V, Unlu M, Boratav C, Babacan A, Soncul H, Halit V, Inanir S, Ersoz A. Psychiatric complications of cardiac surgery postoperative delirium syndrome. Scand Cardiovasc J. 1997;31(4):217-22. doi: 10.3109/14017439709041749.

Reference Type BACKGROUND
PMID: 9291540 (View on PubMed)

Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.

Reference Type BACKGROUND
PMID: 2240918 (View on PubMed)

Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797-811. doi: 10.1192/bjp.114.512.797. No abstract available.

Reference Type BACKGROUND
PMID: 5662937 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

822008

Identifier Type: -

Identifier Source: org_study_id